wexpharma.com was registered 2 decades 8 months ago. It is a domain having .com extension. It is estimated worth of $8.95 and have a daily income of around $0.15. As no active threats were reported recently, wexpharma.com is SAFE to browse.
Daily Unique Visitors: | Not Applicable |
Daily Pageviews: | Not Applicable |
Income Per Day: | $0.15 |
Estimated Worth: | $8.95 |
Google Indexed Pages: | 101 |
Yahoo Indexed Pages: | Not Applicable |
Bing Indexed Pages: | 71 |
Google Backlinks: | 434 |
Bing Backlinks: | Not Applicable |
Alexa BackLinks: | Not Applicable |
Google Pagerank: | Not Applicable |
Alexa Rank: | Not Applicable |
PageSpeed Score: | 57 ON 100 |
Domain Authority: | Not Applicable |
DMOZ Listing: | No |
Google Safe Browsing: | No Risk Issues |
Siteadvisor Rating: | Not Applicable |
WOT Trustworthiness: | Very Poor |
WOT Privacy: | Very Poor |
WOT Child Safety: | Very Poor |
Facebook Shares: | Not Applicable |
Facebook Likes: | Not Applicable |
Facebook Comments: | Not Applicable |
Twitter Count (Tweets): | Not Applicable |
Linkedin Shares: | Not Applicable |
Delicious Shares: | Not Applicable |
Google+: | Not Applicable |
H1 Headings: | Not Applicable | H2 Headings: | Not Applicable |
H3 Headings: | 1 | H4 Headings: | Not Applicable |
H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
Total IFRAMEs: | Not Applicable | Total Images: | 9 |
Google Adsense: | Not Applicable | Google Analytics: | Not Applicable |
Host | Type | TTL | Extra |
---|---|---|---|
wexpharma.com | A | 10799 | IP: 96.53.35.206 |
wexpharma.com | NS | 300 | Target: sp2.domainpeople.com |
wexpharma.com | NS | 300 | Target: sp1.domainpeople.com |
wexpharma.com | SOA | 299 | MNAME: sp1.domainpeople.com RNAME: root.wexpharma.com Serial: 2019061010 Refresh: 28800 Retry: 14400 Expire: 3600000 |
wexpharma.com | MX | 14400 | Priority: 10 Target: mail.wexpharma.com |
wexpharma.com | MX | 14400 | Priority: 20 Target: exserver.wexpharma.com |
wexpharma.com | TXT | 14400 | TXT: v=spf1 mx a a:mail2.wexpharma.cominclude:halneuron.c om -all |